Pharmaceutical
Industry Palestine
Presented By: Talal Nasereddin
Chairman
Bitzeit Pharmaceutical Co.
Email: ceo@bpc.ps
www.bpc.ps
Industry Brief
• Six Companies operate in Palestine
since early 1970s
• Working Capital USD 160 Million
Generic Manufacturing Companies
• Estimated market size is $130 million
Export Market
• 25% of total sales goes to export
market(Germany, East Europe, MENA)
• Investment in Algeria
• Investment in Malta
Market share
Israeli
Palestinian
Foreign
Key Competitive factors
• Modern facilities and equipments
• Improved Management and Production
Processes
• Continuous industry development through
international certification (ISOs and GMP)
Industry Potential Growth
Indicators
Industry Potential Growth
Indicators
Window for Cooperation
• Diversification of products by
introducing new products such as:
Oncology, natural products, herbal
medicine, food supplements, organ
transplantation and specialty products
as (Freeze dried products)
• Packaging
• Grow investments in Algeria
investment environment in
Palestine
• Tax exemptions
• Free trade agreements with Europe,
EFTA, USA, CANADA, Turkey, and the
Arab Countries
• Italian government insurance and
Funding